Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial

BACKGROUND: Delayed onset muscle soreness (DOMS) due to eccentric muscle activity is associated with inflammatory responses and production of reactive oxygen species (ROS) that sustain both inflammation and oxidative stress. Curcumin, a powerful promoter of anti-oxidant response, is one of the best-...

Descripción completa

Detalles Bibliográficos
Autores principales: Drobnic, Franchek, Riera, Joan, Appendino, Giovanni, Togni, Stefano, Franceschi, Federico, Valle, Xavier, Pons, Antoni, Tur, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074833/
https://www.ncbi.nlm.nih.gov/pubmed/24982601
http://dx.doi.org/10.1186/1550-2783-11-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074833/
https://www.ncbi.nlm.nih.gov/pubmed/24982601
http://dx.doi.org/10.1186/1550-2783-11-31

Ejemplares similares